Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Filamin-C (FLNC) is a large, dimeric actin-binding protein predominantly expressed in striated muscle, including cardiac and skeletal muscle. It is composed of an N-terminal actin-binding domain followed by 24 immunoglobulin-like repeats and is essential for maintenance and structural integrity of the Z-disc in the sarcomere. FLNC cross-links actin filaments, anchors membrane proteins to the cytoskeleton, and acts as a mechanosensor to transmit force during muscle contraction. Unique features include specialized insertions and regulated dimerization for muscle-specific functions. Mutations in FLNC cause various muscle diseases, mainly cardiomyopathies and myofibrillar myopathies, highlighting its importance in muscle health and disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Filamin-C (FLNC).